Biommune Technologies In (IMU.CA) Stock Price, Forecast & Analysis
Canada - TSX Venture Exchange - TSX-V:IMU -
IMU.CA Key Statistics, Chart & Performance
The current stock price of IMU.CA is 0.44 null. In the past month the price decreased by -3.3%. In the past year, price increased by 25.71%.
About IMU.CA
Company Profile
bioMmune Technologies Inc is a biopharmaceutical company. The Company is engaged in the research and development of products for the treatment of cancers, and for improvement of the immune system.
Company Info
Biommune Technologies In
400 Burrard Street
Vancouver BC V6C 3A6
CEO: Patrick W. Gray
Phone: +1 604 880-7250
Biommune Technologies In / IMU.CA FAQ
What does IMU do?
bioMmune Technologies Inc is a biopharmaceutical company. The Company is engaged in the research and development of products for the treatment of cancers, and for improvement of the immune system.
What is the stock price of Biommune Technologies In today?
The current stock price of IMU.CA is 0.44 null. The price decreased by -8.33% in the last trading session.
Does IMU stock pay dividends?
IMU.CA does not pay a dividend.
How is the ChartMill rating for Biommune Technologies In?
IMU.CA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
Can you provide the PE ratio for IMU stock?
Biommune Technologies In (IMU.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.05).
Would investing in Biommune Technologies In be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on IMU.CA.
IMU.CA Technical Analysis
IMU.CA Financial Highlights
Over the last trailing twelve months IMU.CA reported a non-GAAP Earnings per Share(EPS) of -0.05.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |